In chronic inflammatory diseases, such as CKD, the hepcidin and ferritin levels are elevated, leading to an impaired availability of iron, and PHD inhibitors have been found to decrease hepcidin levels in CKD patients [109,110,111]. This evidence concerns the gene HAMP and chronic kidney disease.